<DOC>
	<DOCNO>NCT02597907</DOCNO>
	<brief_summary>The purpose study compare antiemetic efficacy aprepitant plus palonosetron versus aprepitant plus ramosetron high risk patient undergo laparoscopic cholecystectomy .</brief_summary>
	<brief_title>Postoperative Nausea Vomiting : Ramosetron Plus Aprepitant v Palonosetron Plus Aprepitant</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Non smoking , female patient , schedule laparoscopic cholecystectomy Patients gastrointestinal disorder , Patients allergies study medication , Patients receive sedative , opioid , steroid antiemetic within 24 h surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>